Results · Professional & Local Services

Genrobotics posts 35% revenue growth in FY26

By Startup Enthusiast · 11 July 2026

What they do

Builds robots for hazardous jobs like sewer cleaning, medical rehab, defence, and space

FY26 revenue ₹43.7 Cr (up 35%), PAT ₹2.6 Cr (nearly 3x); targets ₹219.9 Cr in FY27

Plans ₹150 Cr Series B round; 80-90% for capacity expansion and international growth

Genrobotics reported FY26 operating revenue of ₹43.7 Cr, up 35% from ₹32.5 Cr in FY25.
Profit after tax (PAT) rose to ₹2.6 Cr from ₹90 Lakh, nearly 3x higher.
EBITDA (earnings before interest, taxes, depreciation, and amortisation) grew 74% to ₹6.6 Cr.
EBITDA margin improved to 15.2% from 11.6%; PAT margin rose to 6% from 2.8%.
The company targets ₹219.9 Cr revenue in FY27, over 5x YoY growth.
It plans to raise a ₹150 Cr Series B round in the current fiscal year.
Total funds raised to date exceed ₹100 Cr (including debt).

India's industrial robotics market is projected to grow to $1.55 Bn by 2030.
Genrobotics secured an ₹80 Cr contract from Singapore's PUB in March 2026 for ~44 robots.
It recently led a ₹1 Cr seed round in Estro Tech Robotics.
The company is expanding its patent portfolio in the US as it scales medical robotics there.

Genrobotics builds robots for hazardous and physically demanding jobs.
Its best-known product is Bandicoot, a robot for manual sewer cleaning.
It operates in sanitation, medical robotics, oil & gas, defence, and aerospace/space.
Medical robotics includes rehabilitation systems for stroke, spinal cord injury, and Parkinson's.
Defence products include autonomous rovers for reconnaissance and hazard neutralisation.
Spacetech involves robotic arms for space debris removal and satellite servicing.
Oil & gas: Wilboar robots clean tunnels, ducts, and pipelines in refineries.
Sanitation contributes ~60% of revenue; medical robotics ~40%.
Revenue pipeline for FY27 is ₹155 Cr, with nearly ₹100 Cr already booked.
It has filed over 30 patents and holds 20+ IPs; 10 granted in India, South Africa, Singapore.

Targeting ₹150 Cr Series B round in FY27.
80-90% of fresh capital to expand production capacity; remainder for international presence.
New facility in Kerala to double manufacturing footprint to 60,000 sq ft.
Setting up manufacturing units in Uttar Pradesh and Hyderabad in coming months.
5-year target: manufacturing footprint of 5 Lakh sq ft; annual revenue ₹1,600 Cr.
Expanding patent portfolio in the US as it scales medical robotics there.
Targeting indigenous bipedal-walking demonstration by end of FY27.

Zoho (existing) — Software company; invested in Genrobotics.
Unicorn India Ventures (existing) — Venture capital firm; invested in Genrobotics.
Peak XV Partners (existing) — Venture capital firm; invested in Genrobotics.
Anand Mahindra (existing) — Businessman and chairman of Mahindra Group; invested in Genrobotics.